← Open Payments lookup

RENA LINDEN: Open Payments

NPI 1265081780 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,186 in 103 payments from 13 companies in 2025. Trend: 2023 $1,600 · 2024 $1,541 · 2025 $2,186

Food & beverage: $2,186
CompanyPaymentsAmount
Alkermes, Inc.18$367
Teva Pharmaceuticals USA, Inc.18$343
ABBVIE INC.22$340
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$281
Neurocrine BioSciences, Inc.8$212
Janssen Pharmaceuticals, Inc6$194
Otsuka America Pharmaceutical, Inc.7$167
E.R. Squibb & Sons, L.L.C.5$114
Vanda Pharmaceuticals Inc.3$70
Lundbeck LLC1$29

Products named: VRAYLAR, CAPLYTA, ARISTADA, INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, UZEDY, LYBALVI.

Industry payments across PA — which companies pay providers there.